Details for Patent: 8,956,658
✉ Email this page to a colleague
Which drugs does patent 8,956,658 protect, and when does it expire?
Patent 8,956,658 protects ZELSUVMI and is included in one NDA.
This patent has thirteen patent family members in six countries.
Summary for Patent: 8,956,658
Title: | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
Abstract: | The presently disclosed subject matter relates to nitric oxide-releasing particles for delivering nitric oxide, and their use in biomedical and pharmaceutical applications. |
Inventor(s): | Schoenfisch Mark H., Shin Jae Ho, Stasko Nathan |
Assignee: | The University of North Carolina at Chapel Hill |
Application Number: | US14014939 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 8,956,658
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lnhc | ZELSUVMI | berdazimer sodium | GEL;TOPICAL | 217424-001 | Jan 5, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,956,658
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006249323 | ⤷ Sign Up | |||
Canada | 2606565 | ⤷ Sign Up | |||
Canada | 2912259 | ⤷ Sign Up | |||
European Patent Office | 1888510 | ⤷ Sign Up | |||
European Patent Office | 2669269 | ⤷ Sign Up | |||
European Patent Office | 3556401 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |